Private Health Group Luz Saúde Lifts Annual Profit to €63 Million and Pays Macquarie a First Dividend After Its €310 Million Buy-In
The owner of the Hospital da Luz network will distribute nearly €45 million to shareholders after profit jumped 64% to €63 million, giving Australia's Macquarie its first payout since buying a 40% stake for €310 million.
Luz Saúde, the operator of Portugal's largest private hospital network, is preparing to distribute almost €45 million to its shareholders after a year of double-digit growth — and the payout will hand its newest owner, Australia's Macquarie, its first financial return since it bought into the group.
The company plans to pay out roughly €44.9 million from free reserves, equivalent to €0.47 per share, pending approval at a general assembly on 4 August. The distribution follows a strong 2025: consolidated revenue rose 10% to €807.2 million, while net profit climbed 64% to €63 million. Results were flattered by an €18.1 million one-off gain from an arbitration ruling against the Portuguese State over pandemic-era costs, but the underlying business also expanded.
A first return for Macquarie
The dividend is split between two main owners. Fidelidade — the insurer controlled by China's Fosun and by the state bank Caixa Geral de Depósitos (CGD) — holds about 60% of Luz Saúde and will collect some €27 million. Macquarie, the Australian infrastructure and asset-management group, owns 40% and will receive around €18 million. That marks Macquarie's first payout since it acquired its stake in September 2025 for €310 million, a deal that brought a large international fund into Portuguese private healthcare.
Building out the network
Behind the headline profit is a heavy investment programme. Luz Saúde ploughed €158.9 million into its operations in 2025, nearly double the previous year, with €121.5 million of that going into expanding and upgrading the network. About €84 million was earmarked for new units in Santarém, Leiria and Aveiro, and for the enlargement of Hospital da Luz Torres in Lisbon.
The group runs the Hospital da Luz brand across 15 hospitals and 24 outpatient clinics nationwide, employing more than 7,000 full-time staff. For the growing number of foreign residents who rely on private insurance or pay out of pocket for faster access to specialists, Luz is one of the names most likely to appear on their policy — and its expansion into mid-sized cities such as Santarém and Leiria signals where private operators see the next wave of demand.
Private growth against a strained public system
The results land at a moment when Portugal's public Serviço Nacional de Saúde (National Health Service, or SNS) is grappling with long surgical waiting lists and staffing pressures, trends that have helped push more patients toward private providers. Rising private revenue and profit, alongside continued investment in new hospitals, point to a sector that is consolidating around a handful of large, well-capitalised groups — with international investors increasingly among their shareholders.
For Luz Saúde, the immediate task is to convert its expansion spending into the extra capacity that both its investors and its patients are counting on. The 4 August shareholder vote will formalise the dividend; the harder test will be whether the new hospitals in Santarém, Leiria and Aveiro open on schedule.
Image: the Hospital da Luz building in Lisbon. Photo by Alvesgaspar (Wikimedia Commons, CC BY-SA 4.0).
